3 Reasons Canopy Growth (TSX:WEED) Stock Is Worth Buying

Canopy Growth (TSX:WEED)(NYSE:CGC) is increasingly looking like a reasonable investment for long-term contrarians willing to take the risk.

| More on:

It isn’t easy taking a contrarian stance on an industry that’s been at the centre of the investment community’s attention for the past few years. However, I believe all investors should play devil’s advocate to seek out the best opportunities. 

And Canada’s legal pot sector seems to be screaming out for advocacy at the moment. A wave of legal issues, distribution bottlenecks, regulatory hurdles, lack of cash flow, and shift in sentiment has wiped out nearly half the value of the largest players and pushed smaller ones to the verge of potential bankruptcy. 

Industry leader Canopy Growth (TSX:WEED)(NYSE:CGC) is probably the best example. The stock has lost nearly two-thirds of its value over the past five months or so. With its founder gone and sales coming in lower than expected, things just seem to be getting worse. 

But that doesn’t mean the firm is doomed or worth ignoring. Here are three reasons investors should consider buying, or at least monitoring, the stock over the next few quarters.

Cash

When drinks giant Constellation Brands purchased a hefty chunk of Canopy, it injected $5 billion into the company. Nearly a year later, that cash hoard is down to just $3.8 billion. 

However, that’s still plenty of cash to help the company finance itself for the next two years or so, which means it could bootstrap its way to operational profitability. Meanwhile, the stock trades at 2.3 times cash per share and 1.8 times book value per share. That seems bizarrely low for a company projecting double-digit sales growth going forward. 

New management

Canopy’s notorious founder and leader Bruce Linton was ousted earlier this year, and his replacement hasn’t been picked yet. However, Constellation has installed its chief financial officer David Klein as chairman of the board and Mike Lee as chief financial officer, indicating that financial discipline and better allocation of cash is probably the company’s top priority at this moment. 

I would expect the next CEO to picked in the same vein — focused on “paving a clear path to profitability,” as management said on a recent call with analysts.  

Double-digit growth for a decade

Meanwhile, the global market for legal cannabis continues to mature. Frameworks for legal sales are being installed in several countries, ranging from Thailand to Columbia. By 2025, the legal weed market is expected to reach US$66 billion in sales, implying a double-digit annual growth factor.

Meanwhile, the combined value of Canada’s four largest cannabis companies has shrunk to roughly $20 billion (US$15 billion) at the time of writing. It may be fair to assume that one of these top producers will dominate the global industry once the market matures and stabilizes. In my view, Canopy is well positioned for that. 

Bottom line

As investor sentiment goes from irrational exuberance to serious pessimism, the valuations of these pot stocks are finally getting reasonable. With enough cash to survive for years and new management, Canopy Growth is increasingly looking like a reasonable investment for long-term contrarians willing to take the risk.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. 

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »